Guidelines for consistent reporting of exchanges/to nature within life cycle inventories (LCI)

Data availability and data quality are still critical factors for successful LCA work. The SETAC-Europe LCA Working Group ‘Data Availability and Data Quality' has therefore focused on ongoing developments toward a common data exchange format, public databases and accepted quality measures to find science-based solutions than can be widely accepted. A necessary prerequisite for the free flow and exchange of life cycle inventory (LCI) data and the comparability of LCIs is the consistent definition, nomenclature, and use of inventory parameters. This is the main subject of the subgroup ‘Recommended List of Exchanges' that presents its results and findings here: • Rigid parameter lists for LCIs are not practical; especially, compulsory lists of measurements for all inventories are counterproductive. Instead, practitioners should be obliged to give the rationale for their scientific choice of selected and omitted parameters. The standardized (not: mandatory!) parameter list established by the subgroup can help to facilitate this. • The standardized nomenclature of LCI parameters and the standardized list of measurement bases (units) for these parameters need not be appliedinternally (e.g. in LCA software), but should be adhered to inexternal communications (data for publication and exchange). Deviations need to be clearly stated. • Sum parameters may or may not overlap - misinterpretations in either direction introduce a bias of unknown significance in the subsequent life cycle impact assessments (LCIA). The only person who can discriminate unambiguously is the practitioner who measures or calculates such values. Therefore, a clear statement of independence or overlap is necessary for every sum parameter reported. • Sum parameters should be only used when the group of emissions as such is measured. Individually measured emission parameters should not be hidden in group or sum parameters. • Problematic substances (such as carcinogens, ozone depleting agents and the like) maynever be obscured in group emissions (together with less harmful substances or with substances of different environmental impact), butmust be determined and reported individually, as mentioned in paragraph 3.3 of this article. • Mass and energy balances should be carried out on a unit process level. Mass balances should be done on the level of the entire mass flow in a process as well as on the level of individual chemical elements. • Whenever possible, practitioners should try to fill data gaps with their knowledge of analogous processes, environmental expert judgements, mass balance calculations, worst case assumptions or similar estimation procedure

Untersuchung der Anpassung von Ökobilanzen an spezifische Erfordernisse biotechnischer Prozesse und Produkte

UNTERSUCHUNG DER ANPASSUNG VON ÖKOBILANZEN AN SPEZIFISCHE ERFORDERNISSE BIOTECHNISCHER PROZESSE UND PRODUKTE Untersuchung der Anpassung von Ökobilanzen an spezifische Erfordernisse biotechnischer Prozesse und Produkte / Renner, Isa (Rights reserved) ( -

Mistargeting of peroxisomal EHHADH and inherited renal Fanconi's syndrome

BACKGROUND In renal Fanconi's syndrome, dysfunction in proximal tubular cells leads to renal losses of water, electrolytes, and low-molecular-weight nutrients. For most types of isolated Fanconi's syndrome, the genetic cause and underlying defect remain unknown. METHODS We clinically and genetically characterized members of a five-generation black family with isolated autosomal dominant Fanconi's syndrome. We performed genomewide linkage analysis, gene sequencing, biochemical and cell-biologic investigations of renal proximal tubular cells, studies in knockout mice, and functional evaluations of mitochondria. Urine was studied with the use of proton nuclear magnetic resonance (1H-NMR) spectroscopy. RESULTS We linked the phenotype of this family's Fanconi's syndrome to a single locus on chromosome 3q27, where a heterozygous missense mutation in EHHADH segregated with the disease. The p.E3K mutation created a new mitochondrial targeting motif in the N-terminal portion of EHHADH, an enzyme that is involved in peroxisomal oxidation of fatty acids and is expressed in the proximal tubule. Immunocytofluorescence studies showed mistargeting of the mutant EHHADH to mitochondria. Studies of proximal tubular cells revealed impaired mitochondrial oxidative phosphorylation and defects in the transport of fluids and a glucose analogue across the epithelium. 1H-NMR spectroscopy showed elevated levels of mitochondrial metabolites in urine from affected family members. Ehhadh knockout mice showed no abnormalities in renal tubular cells, a finding that indicates a dominant negative nature of the mutation rather than haploinsufficiency. CONCLUSIONS Mistargeting of peroxisomal EHHADH disrupts mitochondrial metabolism and leads to renal Fanconi's syndrome; this indicates a central role of mitochondria in proximal tubular function. The dominant negative effect of the mistargeted protein adds to the spectrum of monogenic mechanisms of Fanconi's syndrome. (Funded by the European Commission Seventh Framework Programme and others.

The worldwide antibiotic resistance and prescribing in european children (ARPEC) point prevalence survey : Developing hospital-quality indicators of antibiotic prescribing for children

Objectives: Previously, web-based tools for cross-sectional antimicrobial point prevalence surveys (PPSs) have been used in adults to develop indicators of quality improvement. We aimed to determine the feasibility of developing similar quality indicators of improved antimicrobial prescribing focusing specifically on hospitalized neonates and children worldwide. Methods: A standardized antimicrobial PPS method was employed. Included were all inpatient children and neonates receiving an antimicrobial at 8:00 am on the day of the PPS. Denominators included the total number of inpatients. A web-based application was used for data entry, validation and reporting. We analysed 2012 data from 226 hospitals (H) in 41 countries (C) from Europe (174H; 24C), Africa (6H; 4C), Asia (25H; 8C), Australia (6H), Latin America (11H; 3C) and North America (4H). Results: Of 17 693 admissions, 6499 (36.7%) inpatients received at least one antimicrobial, but this varied considerably between wards and regions. Potential indicators included very high broad-spectrum antibiotic prescribing in children of mainly ceftriaxone (ranked first in Eastern Europe, 31.3%; Asia, 13.0%; Southern Europe, 9.8%), cefepime (ranked third in North America, 7.8%) and meropenem (ranked first in Latin America, 13.1%). The survey identified worryingly high use of critically important antibiotics for hospital-acquired infections in neonates (34.9%; range from 14.2% in Africa to 68.0% in Latin America) compared with children (28.3%; range from 14.5% in Africa to 48.9% in Latin America). Parenteral administration was very common among children in Asia (88%), Latin America (81%) and Europe (67%). Documentation of the reasons for antibiotic prescribing was lowest in Latin America (52%). Prolonged surgical prophylaxis rates ranged from 78% (Europe) to 84% (Latin America). Conclusions: Simple web-based PPS tools provide a feasible method to identify areas for improvement of antibiotic use, to set benchmarks and to monitor future interventions in hospitalized neonates and children. To our knowledge, this study has derived the first global quality indicators for antibiotic use in hospitalized neonates and children